SCHEMBL9259917

SCHEMBL9259917

Fc1ccc2c(c1)-c1ncnn1Cc1c(-c3noc(C4CC4)n3)ncn1-2

nearest known ligand 0.77

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GABRG2 P18507 9/20 0.77
GABRB3 P28472 9/20 0.77
GABRA5 P31644 9/20 0.77
GABRA1 P14867 4/20 0.56
GABRB2 P47870 4/20 0.56
GABRA3 P34903 2/20 0.56
GABRA6 Q16445 3/20 0.51
GABRP O00591 1/20 0.51
GABRD O14764 1/20 0.51
GABRB1 P18505 1/20 0.51
GRM5 P41594 1/20 0.51
GABRA2 P47869 1/20 0.51
GABRA4 P48169 1/20 0.51
GABRE P78334 1/20 0.51
GABRG1 Q8N1C3 1/20 0.51
GABRG3 Q99928 1/20 0.51
GABRQ Q9UN88 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9259583 0.90 GABRG2 (0.64) GABRG2GABRB3GABRA5GABRA1GABRB2
SCHEMBL9263501 0.89 GABRG2 (0.65) GABRG2GABRB3GABRA5GABRA1GABRB2
SCHEMBL9259578 0.88 GABRG2 (0.70) GABRG2GABRB3GABRA5GABRA1GABRB2
SCHEMBL9259595 0.87 GABRG2 (1.00) GABRG2GABRB3GABRA5GABRA1GABRB2
SCHEMBL9262828 0.87 GABRA1 (0.61) GABRG2GABRB3GABRA5GABRA1GABRB2
SCHEMBL9254759 0.86 GABRA1 (0.57) GABRG2GABRB3GABRA5GABRA1GABRB2
SCHEMBL9268100 0.86 GABRG2 (0.67) GABRG2GABRB3GABRA5GABRA1GABRB2
SCHEMBL9262704 0.85 GABRG2 (0.73) GABRG2GABRB3GABRA5GABRA1GABRB2
SCHEMBL9265277 0.84 GABRG2 (0.77) GABRG2GABRB3GABRA5GABRA1GABRB2
SCHEMBL9264886 0.84 GABRG2 (0.80) GABRG2GABRB3GABRA5GABRA1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5387585-A Treating epilepsy, anxiety, sleep disorders, schizophrnia, senile dementia HOFFMANN-LA ROCHE INC. (US) 1995-02-07 US claimed
EP-0519307-A2 Tetracyclic Imidazodiazepines F. HOFFMANN-LA ROCHE AG (CH) 1992-12-23 EP claimed
US-5387585-A Treating epilepsy, anxiety, sleep disorders, schizophrnia, senile dementia HOFFMANN-LA ROCHE INC. (US) 1995-02-07 US disclosed
EP-0519307-A2 Tetracyclic Imidazodiazepines F. HOFFMANN-LA ROCHE AG (CH) 1992-12-23 EP disclosed